Rhesus macaque inhibitory and activating KIR3D interact with Mamu-A-encoded ligands

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2156-2163

  Rosner, Cornelia ^a,b   Kruse, Philip H ^a   Hermes, Meike ^a   Otto, Nicole ^a   Walter, Lutz ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; FC RECEPTOR; HYBRID PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL05; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL11; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DLW03; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS05; LIGAND; MACACA MULATTA MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS A1; MACACA MULATTA MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS A3; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOTYPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE COURSE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN INTERACTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMALS; EPITOPES, T-LYMPHOCYTE; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; K562 CELLS; LIGANDS; MACACA MULATTA; PROTEIN INTERACTION MAPPING; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1; RECOMBINANT FUSION PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79951815700     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002634     Document Type: Article

References (50)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
2. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
3. Kelley, J., L. Walter, and J. Trowsdale. 2005. Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet. 1: 129-139.
4. Long, E. O. 2008. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 224: 70-84.
5. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678. (Pubitemid 16119452)
6. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763. (Pubitemid 28064889)
7. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
8. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874. (Pubitemid 39038423)
9. Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39: 733-740.
10. Nelson, G. W., M. P. Martin, D. Gladman, J. Wade, J. Trowsdale, and M. Carrington. 2004. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J. Immunol. 173: 4273-4276. (Pubitemid 39280654)
11. Hiby, S. E., J. J. Walker, K. M. O'shaughnessy, C. W. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965.
12. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 2008. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
13. Yawata, M., N. Yawata, M. Draghi, A. M. Little, F. Partheniou, and P. Parham. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203: 633-645.
14. Hansasuta, P., T. Dong, H. Thananchai, M. Weekes, C. Willberg, H. Aldemir, S. Rowland-Jones, and V. M. Braud. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34: 1673-1679.
15. Rajagopalan, S., Y. T. Bryceson, S. P. Kuppusamy, D. E. Geraghty, A. van der Meer, I. Joosten, and E. O. Long. 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4: e9.
16. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37. (Pubitemid 46033585)
17. Stewart, C. A., F. Laugier-Anfossi, F. Vély, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagné, G. Ferracci, F. A. Arosa, et al. 2005. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 102: 13224-13229.
18. Biassoni, R., A. Pessino, A. Malaspina, C. Cantoni, C. Bottino, S. Sivori, L. Moretta, and A. Moretta. 1997. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27: 3095-3099.
19. Graef, T., A. K. Moesta, P. J. Norman, L. Abi-Rached, L. Vago, A. M. Older Aguilar, M. Gleimer, J. A. Hammond, L. A. Guethlein, D. A. Bushnell, et al. 2009. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206: 2557-2572.
20. Blokhuis, J. H., M. K. van derWiel, G. G. M. Doxiadis, and R. E. Bontrop. 2010. The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics 62: 295-306.
21. Kruse, P. H., C. Rosner, and L. Walter. 2010. Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics 62: 281-293.
22. Otting, N., C. M. Heijmans, R. C. Noort, N. G. de Groot, G. G. Doxiadis, J. J. van Rood, D. I. Watkins, and R. E. Bontrop. 2005. Unparalleled complexity of the MHC class I region in rhesus macaques. Proc. Natl. Acad. Sci. USA 102: 1626-1631.
23. Gardner, M. B., and P. A. Luciw. 2008. Macaque models of human infectious disease. ILAR J. 49: 220-255.
24. Guethlein, L. A., A. M. Older Aguilar, L. Abi-Rached, and P. Parham. 2007. Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J. Immunol. 179: 491-504. (Pubitemid 46986566)
25. Bimber, B. N., A. J. Moreland, R. W. Wiseman, A. L. Hughes, and D. H. O'Connor. 2008. Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J. Immunol. 181: 6301-6308.
26. Sambrook, J. G., A. Bashirova, S. Palmer, S. Sims, J. Trowsdale, L. Abi-Rached, P. Parham, M. Carrington, and S. Beck. 2005. Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res. 15: 25-35.
27. Otting, N., A. J. de Vos-Rouweler, C. M. Heijmans, N. G. de Groot, G. G. Doxiadis, and R. E. Bontrop. 2007. MHC class I A region diversity and polymorphism in macaque species. Immunogenetics 59: 367-375.
28. Otting, N., C. M. Heijmans, M. van der Wiel, N. G. de Groot, G. G. Doxiadis, and R. E. Bontrop. 2008. A snapshot of the Mamu-B genes and their allelic repertoire in rhesus macaques of Chinese origin. Immunogenetics 60: 507-514.
29. Karl, J. A., R. W. Wiseman, K. J. Campbell, A. J. Blasky, A. L. Hughes, B. Ferguson, D. S. Read, and D. H. O'Connor. 2008. Identification of MHC class I sequences in Chinese-origin rhesus macaques. Immunogenetics 60: 37-46.
30. Daza-Vamenta, R., G. Glusman, L. Rowen, B. Guthrie, and D. E. Geraghty. 2004. Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res. 14: 1501-1515.
31. Mothé, B. R., J. Weinfurter, C. Wang, W. Rehrauer, N. Wilson, T. M. Allen, D. B. Allison, and D. I. Watkins. 2003. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 77: 2736-2740.
32. Sauermann, U., R. Siddiqui, Y. S. Suh, M. Platzer, N. Leuchte, H. Meyer, K. Mätz-Rensing, H. Stoiber, P. Nürnberg, G. Hunsmann, et al. 2008. Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun. 9: 69-80. (Pubitemid 351150037)
33. Rosner, C., P. H. Kruse, T. Lübke, and L. Walter. 2010. Rhesus macaque MHC class I molecules show differential subcellular localizations. Immunogenetics 62: 149-158.
34. Urvater, J. A., N. Otting, J. H. Loehrke, R. Rudersdorf, I. I. Slukvin, M. S. Piekarczyk, T. G. Golos, A. L. Hughes, R. E. Bontrop, and D. I. Watkins. 2000. Mamu-I: a novel primate MHC class I B-related locus with unusually low variability. J. Immunol. 164: 1386-1398.
35. Gumperz, J. E., L. D. Barber, N. M. Valiante, L. Percival, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 158: 5237-5241. (Pubitemid 127681227)
36. Sanjanwala, B., M. Draghi, P. J. Norman, L. A. Guethlein, and P. Parham. 2008. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J. Immunol. 181: 6293-6300.
37. Yant, L. J., T. C. Friedrich, R. C. Johnson, G. E. May, N. J. Maness, A. M. Enz, J. D. Lifson, D. H. O'Connor, M. Carrington, and D. I. Watkins. 2006. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80: 5074-5077.
38. Mühl, T., M. Krawczak, P. Ten Haaft, G. Hunsmann, and U. Sauermann. 2002. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169: 3438-3446. (Pubitemid 35013195)
39. Fadda, L., G. Borhis, P. Ahmed, K. Cheent, S. V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, F. H. Claas, et al. Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 107: 10160-10165.
40. Khakoo, S. I., R. Geller, S. Shin, J. A. Jenkins, and P. Parham. 2002. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 196: 911-921.
41. Khakoo, S. I., R. Rajalingam, B. P. Shum, K.Weidenbach, L. Flodin, D. G. Muir, F. Canavez, S. L. Cooper, N. M. Valiante, L. L. Lanier, and P. Parham. 2000. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12: 687-698.
42. Moffett, A., and C. Loke. 2006. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6: 584-594.
43. Abi-Rached, L., H. Kuhl, C. Roos, B. ten Hallers, B. Zhu, L. Carbone, P. J. de Jong, A. R. Mootnick, F. Knaust, R. Reinhardt, et al. 2010. A small, variable, and irregular killer cell Ig-like receptor locus accompanies the absence of MHC-C and MHC-G in gibbons. J. Immunol. 184: 1379-1391.
44. Valés-Gómez, M., H. T. Reyburn, R. A. Erskine, and J. Strominger. 1998. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl. Acad. Sci. USA 95: 14326-14331.
45. Qi, Y., M. P. Martin, X. Gao, L. Jacobson, J. J. Goedert, S. Buchbinder, G. D. Kirk, S. J. O'Brien, J. Trowsdale, and M. Carrington. 2006. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2: e79.
46. Alter, G., M. P. Martin, N. Teigen, W. H. Carr, T. J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, C. Brander, et al. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204: 3027-3036.
47. Pereira, L. E., R. P. Johnson, and A. A. Ansari. 2008. Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell. Immunol. 254: 10-19.
48. Brunetta, E., K. L. Hudspeth, and D. Mavilio. 2010. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J. Leukoc. Biol. 88: 1119-1130.
49. Bostik, P., J. Kobkitjaroen, W. Tang, F. Villinger, L. E. Pereira, D. M. Little, S. T. Stephenson, M. Bouzyk, and A. A. Ansari. 2009. Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J. Immunol. 182: 3638-3649.
50. Wiseman, R. W., J. A. Karl, B. N. Bimber, C. E. O'Leary, S. M. Lank, J. J. Tuscher, A. M. Detmer, P. Bouffard, N. Levenkova, C. L. Turcotte, et al. 2009. Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat. Med. 15: 1322-1326.